Isoflurane-Assisted Electroacupuncture in a Rat Model of Oligoasthenozoospermia

Summary

This protocol details the establishment of an adenine-induced oligoasthenozoospermia model in rats and the subsequent delivery of electroacupuncture at CV3, CV4, ST36, and SP6 under isoflurane anesthesia. Outcomes were verified using computer-assisted sperm analysis for count and motility, alongside testicular histology with hematoxylin and eosin staining.

Abstract

Oligoasthenozoospermia is one of the most common forms of male reproductive dysfunction. In rodent studies, delivering electroacupuncture (EA) consistently across repeated sessions poses a technical challenge, particularly when combining abdominal midline and hind-limb acupoints, where stable electrode contact is critical. Zhongji (CV3), Guanyuan (CV4), Zusanli (ST36), and Sanyinjiao (SP6) were selected because these points are frequently used in acupuncture protocols for infertility and semen abnormalities, and the abdominal midline plus hind-limb configuration suits standardized electrode pairing. This report describes a practical protocol for establishing an adenine-induced rat model of oligoasthenozoospermia and for administering isoflurane-assisted EA with paired stimulation of CV3–CV4 and ST36–SP6. Male Sprague-Dawley rats received adenine by daily gavage for 28 days to induce reproductive impairment. Subsequently, EA was administered daily for 28 days under inhalational anesthesia, using 3% isoflurane for induction and 1.5% for mask maintenance, to enable stable needle placement and electrode pairing (CV3–CV4 and ST36–SP6) with defined stimulation parameters (2 Hz, 1.5 mA, 30 min). Treatment effects were evaluated via computer-assisted semen analysis for sperm count and motility, supplemented by testicular hematoxylin and eosin (HE) histology. Representative results indicate that adenine exposure reduced sperm count and motility and disrupted seminiferous tubule architecture, while EA was associated with partial recovery in both semen parameters and testicular morphology. This protocol offers a ready reference for studies requiring consistent EA delivery and semen/histological verification in a rat model of oligoasthenozoospermia.

Introduction

Male factors contribute substantially to infertility, accounting for approximately half of all infertile couples, with abnormalities in sperm count and motility being among the most common clinical findings^1,2. Oligoasthenozoospermia, characterized by reduced sperm concentration and impaired motility, is one of the most common forms of male reproductive dysfunction^3,4. Despite the availability of assisted reproductive techniques and empirical medical therapies, effective strategies to improve semen quality remain limited, highlighting the need for further preclinical investigation^5,6,7. These clinical and translational needs motivate the development of reproducible experimental workflows to study male reproductive impairment under controlled conditions.

Acupuncture interventions have been investigated for semen abnormalities and male infertility in both clinical and experimental contexts⁸. Although clinical studies suggest potential benefits for certain semen parameters, their designs, intervention protocols, and outcome measures vary widely⁹. Electroacupuncture (EA) is particularly suitable for laboratory research because it offers controlled stimulation parameters and more uniform regulation than manual acupuncture, which facilitates assessing treatment-related changes in measurable reproductive outcomes^10,11,12. This procedural advantage makes EA well-suited to structured preclinical workflows in male reproductive research.

Animal models are central to such evaluation, but model selection remains a key methodological issue in oligoasthenozoospermia research. A recent systematic review noted that busulfan-induced modeling methods are controversial and exhibit substantial heterogeneity in evaluation indices, highlighting the need for clearer procedures and more consistent readouts¹³. Adenine-based models provide a practical experimental approach because adenine gavage can induce reproductive impairment in rats, including reduced sperm-related endpoints and histological damage in testicular tissue^14,15. In our previous work, an adenine-induced oligoasthenozoospermia rat model was treated with EA at a Shu-Mu brain-kidney acupoint set (Epangsanxian, BL23, GB25, and KI3), alongside non-acupoint and positive-drug control conditions, with expanded outcome measures that included organ coefficients and serum hormone levels quantified by ELISA¹⁶. Building on this experimental foundation and recognizing the heterogeneity in acupoint selection, control design, stimulation parameters, and outcome measures across existing EA studies, the present protocol was designed to refine and extend the methodological workflow for stable EA delivery.

Accordingly, the present protocol focuses on delivery, addressing two practical variables critical for repeated EA sessions in rodents. First, to prevent needle displacement and intermittent electrode contact caused by animal movement and lead-wire traction, we describe an isoflurane-maintained procedure that stabilizes positioning during stimulation and ensures reliable electrode contact across sessions; this is particularly important when combining abdominal midline points with hind-limb points. Second, based on prior reviews and acupoint-prescription analyses^9,17, identifying CV4, SP6, ST36, and CV3 as common reproductive acupoints in infertility and semen-abnormality protocols, we selected CV3, CV4, ST36, and SP6 and applied paired stimulation to CV3-CV4 and ST36-SP6. This configuration, which combines abdominal midline and hind-limb points, standardizes electrode connections, minimizes variability caused by unstable lead attachment, and supports reproducible EA delivery across repeated treatment sessions. To maintain a protocol-oriented scope and avoid duplicating previously reported endocrine, mechanistic, or positive-control modules, outcome verification is limited to a primary semen-and-testis readout set. This set comprises computer-assisted sperm analysis and testicular HE staining, which are sufficient to confirm successful phenotype induction and treatment-associated changes within this workflow.

Protocol

All animal procedures complied with institutional guidelines for the care and use of laboratory animals and were approved by the Ethics Committee of Ningxia Medical University (approval no. IACUC-NYLAC-2021-130). Male Sprague-Dawley rats, aged 8 weeks and weighing 180–220 g, were obtained from the Experimental Animal Center of Ningxia Medical University (license no. SYXK (Ning) 2020-0001). The animals were housed under standard laboratory conditions at 22–24 °C and 52%–56% relative humidity with a 12 h light/12 h dark cycle, and they had free access to food and water.

1. Animal preparation, group assignment, and adenine-induced model establishment

1. Acclimate the rats for 7 days prior to the experiment and monitor their general condition daily.
2. After acclimatization, assign nine rats unique identification numbers and randomly allocate them at a 1:1:1 ratio into three groups using a computer-generated randomization sequence: a control group (n = 3), a model group (n = 3), and an EA group (n = 3). Use each rat as the experimental unit, and include all animals and samples in the final analysis unless predefined exclusion criteria are met.
3. Keep the investigators performing computer-assisted semen analysis and histological assessment blinded to group allocation.
   NOTE: The investigators delivering EA cannot be blinded because the intervention involves visible group-specific procedures.
4. Prepare a 20 mg/mL suspension of adenine in normal saline containing 0.5% (w/v) gum arabic as a suspending agent, and mix thoroughly both before and during gavage to prevent sedimentation.
5. Administer normal saline to the control group and adenine suspension to the model and EA groups via gavage at 10 mL/kg, equivalent to 1 mL/100 g body weight, once daily for 28 consecutive days. Use an adenine dose of 200 mg/kg/day.
6. Record body weight and general condition throughout the modeling period.
   NOTE: Adenine is administered as a suspension and tends to sediment during handling. Maintain continuous agitation during gavage to minimize precipitation, which can otherwise cause dosing inconsistency and blockage of the gavage needle. If clogging occurs, re-suspend the solution thoroughly and replace the gavage needle before continuing.

2. Isoflurane anesthesia for electroacupuncture delivery (Figure 1)

1. Prepare an isoflurane anesthesia system with an induction chamber, a nose mask, and a heating pad.
2. Induce anesthesia with 3% isoflurane in the induction chamber until spontaneous activity decreases markedly.
3. Transfer the rat to the heating pad in the supine position, and maintain anesthesia with 1.5% isoflurane via a nose mask throughout EA.
4. Confirm adequate anesthesia by reduced spontaneous movement and loss of the blink reflex while maintaining regular respiration.

3. Stimulation delivery fidelity and quality control

1. Use a heating pad to maintain body temperature throughout the session and reduce physiological variability due to hypothermia.
2. Apply consistent anesthesia settings across all animals and sessions, using 3% isoflurane for induction and 1.5% isoflurane for maintenance. Keep the anesthetic depth at the minimum level needed to prevent struggling while maintaining regular respiration.
3. Insert sterile disposable acupuncture needles (0.25 mm × 13 mm) vertically at the selected acupoints. Insert the needles to depths of approximately 2 mm at CV3 and CV4, 7 mm at ST36, and 5 mm at SP6.
4. After needle insertion and electrode connection, visually confirm that each needle remains stably positioned, with no observable loosening due to respiration or limb movement. If displacement occurs, reinsert the needle vertically to the original depth and verify stable electrode contact before resuming stimulation.
5. Clip the electrode leads near the proximal end of the needle handle, then route and secure them to minimize traction, as lead weight and tugging are common causes of detachment.
6. Confirm effective stimulation by observing a mild local muscle tremor at the acupoint without gross body movement. If no tremor is present, recheck and reconfirm electrode contact and needle placement.
7. Perform a single standardized check midway through the session at 15 min. If necessary, readjust the needles and reconfirm mild local tremor before proceeding to reduce variability in stimulation delivery across animals.
   NOTE: When connecting the EA device, clip the leads to the proximal end of the needle handle to reduce traction from cable weight. If needed, secure the lead and/or needle with tape to prevent detachment during the session.

4. Electroacupuncture treatment (Figure 2)

1. Initiate EA on the day following the 28-day adenine gavage period, and administer it once daily for 28 consecutive days.
2. Under isoflurane anesthesia, expose the lower abdomen and hind limbs, and locate Zhongji (CV3), Guanyuan (CV4), Zusanli (ST36), and Sanyinjiao (SP6) using surface anatomical landmarks.
3. Insert sterile disposable acupuncture needles (0.25 mm × 13 mm) vertically to depths of 2 mm at CV3 and CV4, 7 mm at ST36, and 5 mm at SP6.
4. Connect one pair of electrodes to CV3 and CV4, and connect the other pair to ST36 and SP6.
5. Deliver electrical stimulation at 2 Hz and 1.5 mA for 30 min. Use these parameters to match those employed previously on adenine-induced oligoasthenozoospermia¹⁶.
6. Apply the quality control checks outlined in Section 3, including a single mid-session check at 15 min.
   NOTE: Localize rat acupoints with reference to Yong Tang’s Experimental Acupuncture and Moxibustion Science¹⁸, Appendix II (“Acupuncture Points Commonly Used in Experimental Animals”), together with comparative anatomical landmarks. Because rat acupoints represent discrete anatomical regions rather than fixed geometric points, use a consistent body position, fixed anatomical reference points, and millimeter-based surface measurements across animals and sessions. Locate Zhongji (CV3) on the ventral midline approximately 33 mm caudal to the center of the umbilicus. Locate Guanyuan (CV4) on the ventral midline approximately 25 mm caudal to the center of the umbilicus, near the subcutaneous superficial arteries of the abdominal wall. Locate Zusanli (ST36) on the posterolateral aspect of the knee, approximately 3 mm distal to the fibular head. Locate Sanyinjiao (SP6) on the medial aspect of the hind limb, approximately 10 mm proximal to the tip of the medial malleolus. Apply the same localization references, body position, insertion angle, and insertion depth consistently across all animals and treatment sessions.

5. Sample collection

1. Fast the rats for 24 h following the final EA session.
2. Induce deep anesthesia via intraperitoneal injection of 2% pentobarbital sodium at 2 mL/kg before tissue collection. Confirm deep anesthesia by the absence of the pedal withdrawal reflex and spontaneous movement.
3. Euthanize the rat by decapitation under deep anesthesia, following institutionally approved protocols.
4. Immediately expose the reproductive organs aseptically. Isolate one cauda epididymis for sperm analysis and excise one testis for histological examination.
5. Fix the testis in 4% paraformaldehyde for at least 24 h before histological processing.

6. Sperm analysis

1. Remove the surrounding fat from the cauda epididymis, and immediately place the tissue into 2 mL of normal saline prewarmed to 37 °C.
2. Incubate the tissue in a 37 °C water bath for 5 min, mince it with ophthalmic scissors, filter the suspension through a 200-mesh screen, and gently mix the filtrate.
3. Load a 10 µL aliquot of the sperm suspension into a prewarmed counting chamber, and analyze sperm count and motility using a computer-assisted semen analysis (CASA) system.
4. Use the same chamber type, warming conditions, and acquisition settings for all samples within a given experiment.

7. Histological examination of testicular tissue

1. Fix the testicular tissue in 4% paraformaldehyde for a minimum of 24 h. Trim the target area and place it into labeled cassettes.
2. Dehydrate the samples through a graded ethanol series, clear them in xylene, infiltrate them with paraffin, embed them, and section them at 4 µm.
3. Float the sections on a 40 °C water bath, mount them onto slides, and dry them in a 60 °C oven.
4. For hematoxylin and eosin staining, dewax the sections in xylene, rehydrate them through graded ethanol, stain them with hematoxylin for 5–10 min and eosin for 1–5 min, then dehydrate, clear, and mount them.
5. Examine seminiferous tubule organization and spermatogenic cell arrangement under consistent magnification settings across all groups.

8. Evaluation of model establishment and treatment-associated changes

1. Confirm model establishment by a reduction in sperm count and motility, together with disorganized seminiferous tubule structure, relative to the control group.
2. Confirm treatment-associated changes by increased sperm count and motility, together with partial restoration of seminiferous tubule morphology, in the EA group relative to the model group.
3. Predefine technically compromised samples, such as those with delayed sperm processing, chamber-loading failure, or low-quality sections unrelated to modeling, as exclusion criteria. Document any exclusions during analysis.

Results

Sperm analysis (Figure 3)
Epididymal sperm suspensions were analyzed using a computer-assisted semen analysis system to quantify sperm count and motility. In this representative dataset, adenine administration markedly reduced both parameters relative to the control group, confirming successful model establishment. EA intervention subsequently increased sperm count and motility compared to the model group (Figure 3). One-way ANOVA indicated significant group effects for ...

Discussion

Given the multifactorial etiology of oligoasthenozoospermia and the limited efficacy of available pharmacologic treatments, acupuncture and EA have gained attention as repeatable, nonpharmacological interventions¹⁹. The existing clinical and preclinical literature suggests several plausible mechanisms by which acupuncture or EA may influence male reproductive function, including the modulation of neuroendocrine regulation, improvement of reproductive organ microcirculation, and attenuation of oxid...

Materials

List of materials used in this article

Name	Company	Catalog Number	Comments
Adenine	Beijing Solarbio Science & Technology Co.Ltd.	A8330
CASA computer-assisted semen analysis system	Nanning Songjing Tianlun Biotechnology Co.,Ltd.	VICOS-SPERM
Centrifuge	Sartorius	A-14C
Differentiation fluid	Shanghai Biyuntian Biotechnology Co.,Ltd	C0163M
Disposable sterile acupuncture needles	Hanyi brand		0.25 mm ´ 13 mm
Drying machine	Leica	HI1220
Electrical stimulator	Changzhou Yingdi Electronic Medical Device Co., Ltd	KWD-808I
Electronic balance	Hangzhou Youheng Weighing Equipment Co.,Ltd	HLD-6002
Eosin Y Stain Solution	Lanke Biotech	BS248
Hematoxylin staining solution	Zhuhai Beso Biotechnology Co. LTD	BA-4041
Isoflurane	RWD Life Science Co., Ltd.	R510-22-10
Microtome	Leica	RM2255
Neutral balsam	Beijing Zhongshan Jinqiao Biotechnology Co.,Ltd	Zli-9555
Paraffin embedding machine	Leica	HistoCore Arcadia H
SD rats	Animal Center of Ningxia Medical University		8-week-old,Male,180-220 g
Slide scanner	Leica	Aperio LV1
Small Animal Anesthesia Machine	RWD Life Science Co., Ltd.	R500
Vortex oscillator	Haimen Qilin Bell Instrument Manufacturing Co.,Ltd	QL-902
Warming pad	Dongguan Hongda Electronics Co., Ltd.	45W-80X28CM